Pay Attention to High-risk Factors，Standardize Management，and Reasonably Diagnose and Treat Thromboembolic Diseases during Pregnancy——Interpretation of ACOG Practice Bulletin No.196：Thromboembolism in Pregnancy（2018）

doi:10.12114/j.issn.1007-9572.2018.00.244

Abstract

Abstract: In recent years，the incidence of thromboembolism in pregnancy is increasing，which is one of the main causes of maternal mortality.In 2018，the American College of Obstetricians and Gynecologists updated its guidelines to provide information regarding the high-risk factors，use of anticoagulant drugs in pregnancy，diagnosis，intrapartum / postnatal management，and so on，and this Practice Bulletin replaces Practice Bulletin No.123（2011）．The clinical recommendations from the ACOG guidelines are interpreted according to evidence-based practices，in order to better guide the clinical work.

Key words: Thromboembolism, Pregnant women, Venous thrombosis, Pulmonary embolism, Clinical governance, Guidebooks

摘要： 近年来，妊娠期血栓栓塞性疾病的发病率呈上升趋势，是孕产妇死亡的主要原因之一。2018年美国妇产科医师学会（ACOG）更新了于2011年制定的《妊娠期血栓栓塞症的临床管理指南》，在妊娠期血栓栓塞性疾病的高危因素、妊娠期抗凝药物的使用、诊断、产时/产后管理等方面进行了部分更新。现根据该指南更新的循证医学证据，对该指南给出的推荐意见做一解读，以期更好地指导临床工作。

关键词: 血栓栓塞, 孕妇, 静脉血栓形成, 肺栓塞, 临床管理, 指南

LIN Li,WANG Jing. Pay Attention to High-risk Factors，Standardize Management，and Reasonably Diagnose and Treat Thromboembolic Diseases during Pregnancy——Interpretation of ACOG Practice Bulletin No.196：Thromboembolism in Pregnancy（2018）　[J]. Chinese General Practice, 2018, 21(30): 3659-3664. DOI: 10.12114/j.issn.1007-9572.2018.00.244.
蔺莉,王静. 重视高危因素，规范管理、合理诊治妊娠期血栓栓塞性疾病——《2018 ACOG实践简报：妊娠期血栓栓塞症的临床管理指南》解读[J]. 中国全科医学, 2018, 21(30): 3659-3664. DOI: 10.12114/j.issn.1007-9572.2018.00.244.

References

［1］POMP E R，LENSELINK A M，ROSENDAAL F R，et al．Pregnancy，the postpartum period and prothrombotic defects：risk of venous thrombosis in the MEGA study［J］．J Thromb Haemost，2008，6（4）：632-637．DOI：10.1111/j.1538-7836.2008.02921.x.3662
［2］CREANGA A A，SYVERSON C，SEED K，et al．Pregnancy-related mortality in the United States，2011—2013［J］．Obstet Gynecol，2017，130（2）：366-373．DOI：10.1097/AOG.0000000000002114.3662
［3］JAMES A，Committee on Practice Bulletins-Obstetrics.Practice bulletin No.123：thromboembolism in pregnancy［J］．Obstet Gynecol，2011，118（3）：718-729．DOI：10.1097/AOG.0b013e3182310c4c.3662
［4］ACOG practice bulletin No.196：thromboembolism in pregnancy［J］．Obstet Gynecol，2018，132（1）：e1-17．DOI：10.1097/AOG.0000000000002706.3662
［5］ANTONY K M，RACUSIN D A，AAGAARD K，et al．Maternal physiology［M］//GABBE S G，NIEBYL J R，SIMPSON J L，et al．Obstetrics：normal and problem pregnancies.7th ed.Philadelphia（PA）：Elsevier，2017：38-63.3662
［6］MACKLON N S，GREER I A.Venous thromboembolic disease in obstetrics and gynaecology：the Scottish experience［J］．Scott Med J，1996，41（3）：83-86．DOI：10.1177/003693309604100305.3662
［7］WHITTY J E，DOMBROWSKI M P.Respiratory disease in pregnancy［M］//GABBE S G，NIEBYL J R，SIMPSON J L，et al．Obstetrics：normal and problem pregnancies.7th ed.Philadelphia（PA）：Elsevier，2017：828-849.3662
［8］SIKOVANYECZ J，ORVOS H，PáL A，et al．Leiden mutation，bed rest and infection：simultaneous triggers for maternal deep-vein thrombosis and neonatal intracranial hemorrhage?［J］．Fetal Diagn Ther，2004，19（3）：275-277．DOI：10.1159/000076711.3662
［9］JAMES A H，TAPSON V F，GOLDHABER S Z.Thrombosis during pregnancy and the postpartum period［J］．Am J Obstet Gynecol，2005，193（1）：216-219．DOI：10.1016/j.ajog.2004.11.037.3663
［10］PABINGER I，GRAFENHOFER H，KYRLE P A，et al．Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism［J］．Blood，2002，100（3）：1060-1062．DOI：10.1182/blood-2002-01-0149.3663
［11］JAMES A H，JAMISON M G，BRANCAZIO L R，et al．Venous thromboembolism during pregnancy and the postpartum period：incidence，risk factors，and mortality［J］．Am J Obstet Gynecol，2006，194（5）：1311-1315．DOI：10.1016/j.ajog.2005.11.008.3663
［12］JAMES A H.Venous thromboembolism in pregnancy［J］．Arterioscler Thromb Vasc Biol，2009，29（3）：326-331．DOI：10.1161/ATVBAHA.109.184127.3663
［13］ACOG practice bulletin No.197：inherited thrombophilias in pregnancy［J］．Obstet Gynecol，2018，132（1）：e18-34．DOI：10.1097/AOG.0000000000002703.3663
［14］BLONDON M，CASINI A，HOPPE K K，et al．Risks of venous thromboembolism after cesarean sections：a meta-analysis［J］．Chest，2016，150（3）：572-596．DOI：10.1016/j.chest.2016.05.021.3663
［15］Royal College of Obstetricians and Gynaecologists.Reducing the risk of venous thromboembolism during pregnancy and the puerperium.Green Top Guideline No.37a［M/OL］．London（UK）：RCOG，2015.https：//www.rcog.org.uk/globalassets/documents/guidelines/gtg-37a.pdf.3663
［16］HARENBERG J，SCHNEIDER D，HEILMANN L，et al．Lack of anti-factor Xa activity in umbilical cord vein samples after subcutaneous administration of heparin or low molecular mass heparin in pregnant women［J］．Haemostasis，1993，23（6）：314-320．DOI：10.1159/000216894.3663
［17］GREER I A，NELSON-PIERCY C.Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy：a systematic review of safety and efficacy［J］．Blood，2005，106（2）：401-407．DOI：10.1182/blood-2005-02-0626.3663
［18］LEBAUDY C，HULOT J S，AMOURA Z，et al．Changes in enoxaparin pharmacokinetics during pregnancy and implications for antithrombotic therapeutic strategy［J］．Clin Pharmacol Ther，2008，84（3）：370-377．DOI：10.1038/clpt.2008.73.3663
［19］REGENSTEIN A.Risk of warfarin during pregnancy with mechanical valve prostheses［J］．Obstet Gynecol，2002，100（5 Pt 1）：1040-1041.3663
［20］ITURBE-ALESSIO I，FONSECA M C，MUTCHINIK O，et al．Risks of anticoagulant therapy in pregnant women with artificial heart valves［J］．N Engl J Med，1986，315（22）：1390-1393．DOI：10.1056/NEJM198611273152205.3663
［21］VAN HAGEN I M，ROOS-HESSELINK J W，RUYS T P，et al．Pregnancy in women with a mechanical heart valve：data of the European society of cardiology registry of pregnancy and cardiac disease（ROPAC）［J］．Circulation，2015，132（2）：132-142．DOI：10.1161/CIRCULATIONAHA.115.015242.3663
［22］OKOROH E M，AZONOBI I C，GROSSE S D，et al．Prevention of venous thromboembolism in pregnancy：a review of guidelines，2000—2011［J］．J Womens Health（Larchmt），2012，21（6）：611-615．DOI：10.1089/jwh.2012.3600.3663
［23］CHAN W S，LEE A，SPENCER F A，et al．Predicting deep venous thrombosis in pregnancy：out in “LEFt” field?［J］．Ann Intern Med，2009，151（2）：85-92.3663
［24］CHAN W S，SPENCER F A，GINSBERG J S.Anatomic distribution of deep vein thrombosis in pregnancy［J］．CMAJ，2010，182（7）：657-660．DOI：10.1503/cmaj.091692.3663
［25］NIJKEUTER M，GINSBERG J S，HUISMAN M V.Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy：a systematic review［J］．J Thromb Haemost，2006，4（3）：496-500．DOI：10.1111/j.1538-7836.2005.01779.x.3663
［26］BATES S M，JAESCHKE R，STEVENS S M，et al．Diagnosis of DVT：antithrombotic therapy and prevention of thrombosis，9th ed：American College of Chest Physicians Evidence-Based Clinical Practice Guidelines［J］．Chest，2012，141（2 Suppl）：e351S-418．DOI：10.1378/chest.11-2299.3663
［27］VAN DER POL L M，MAIRUHU A T，TROMEUR C，et al．Use of clinical prediction rules and D-dimer tests in the diagnostic management of pregnant patients with suspected acute pulmonary embolism［J］．Blood Rev，2017，31（2）：31-36．DOI：10.1016/j.blre.2016.09.003.3663
［28］CHUNILAL S D，BATES S M.Venous thromboembolism in pregnancy：diagnosis，management and prevention［J］．Thromb Haemost，2009，101（3）：428-438.3663
［29］LEUNG A N，BULL T M，JAESCHKE R，et al．American Thoracic Society documents：an official American Thoracic Society/Society of Thoracic Radiology Clinical Practice Guideline——Evaluation of Suspected Pulmonary Embolism in Pregnancy［J］．Radiology，2012，262（2）：635-646．DOI：10.1148/radiol.11114045.3663
［30］Committee on Practice Bulletins-Obstetrics，American College of Obstetricians and Gynecologists.Practice Bulletin No.132：antiphospholipid syndrome［J］．Obstet Gynecol，2012，120（6）：1514-1521．DOI：10.1097/01.AOG.0000423816.39542.0f.3663
［31］BRILL-EDWARDS P，GINSBERG J S，GENT M，et al．Safety of withholding heparin in pregnant women with a history of venous thromboembolism.Recurrence of Clot in This Pregnancy Study Group［J］．N Engl J Med，2000，343（20）：1439-1444．DOI：10.1056/NEJM200011163432002.3663
［32］MCLINTOCK C，BRIGHTON T，CHUNILAL S，et al．Recommendations for the diagnosis and treatment of deep venous thrombosis and pulmonary embolism in pregnancy and the postpartum period［J］．Aust N Z J Obstet Gynaecol，2012，52（1）：14-22．DOI：10.1111/j.1479-828X.2011.01361.x.3663
［33］CHAN W S，REY E，KENT N E，et al．Venous thromboembolism and antithrombotic therapy in pregnancy［J］．J Obstet Gynaecol Can，2014，36（6）：527-553.3664
［34］LYKKE J A，GR?NLYKKE T，LANGHOFF-ROOS J.Treatment of deep venous thrombosis in pregnant women［J］．Acta Obstet Gynecol Scand，2008，87（11）：1248-1251．DOI：10.1080/00016340802449118.3664
［35］SAGARAM D，SIDDIQ Z，EISENBERGER A B，et al．Heparin-induced thrombocytopenia during obstetric hospital admissions［J］．Am J Perinatol，2018，35（9）：898-903．DOI：10.1055/s-0038-1627096.3664
［36］LINKINS L A，DANS A L，MOORES L K，et al．Treatment and prevention of heparin-induced thrombocytopenia：Antithrombotic Therapy and Prevention of Thrombosis，9th ed：American College of Chest Physicians Evidence-Based Clinical Practice Guidelines［J］．Chest，2012，141（2 Suppl）：e495S-530．DOI：10.1378/chest.11-2303.3664
［37］BATES S M，MIDDELDORP S，RODGER M，et al．Guidance for the treatment and prevention of obstetric-associated venous thromboembolism［J］．J Thromb Thrombolysis，2016，41（1）：92-128．DOI：10.1007/s11239-015-1309-0.3664
［38］BATES S M，GREER I A，MIDDELDORP S，et al．VTE，thrombophilia，antithrombotic therapy，and pregnancy：antithrombotic therapy and prevention of thrombosis，9th ed：American College of Chest Physicians Evidence-Based Clinical Practice Guidelines［J］．Chest，2012，141（2 Suppl）：e691S-736．DOI：10.1378/chest.11-2300.3664
［39］LEFFERT L，BUTWICK A，CARVALHO B，et al．The society for obstetric anesthesia and perinatology consensus statement on the anesthetic management of pregnant and postpartum women receiving thromboprophylaxis or higher dose anticoagulants［J］．Anesth Analg，2018，126（3）：928-944．DOI：10.1213/ANE.0000000000002530.3664
［40］TEPPER N K，BOULET S L，WHITEMAN M K，et al．Postpartum venous thromboembolism：incidence and risk factors［J］．Obstet Gynecol，2014，123（5）：987-996．DOI：10.1097/AOG.0000000000000230.3664
［41］FREEDMAN R A，BAUER K A，NEUBERG D S，et al．Timing of postpartum enoxaparin administration and severe postpartum hemorrhage［J］．Blood Coagul Fibrinolysis，2008，19（1）：55-59．DOI：10.1097/MBC.0b013e3282f185dd.3664
［42］SACHS H C，Committee on Drugs.The transfer of drugs and therapeutics into human breast milk：an update on selected topics［J］．Pediatrics，2013，132（3）：e796-809．DOI：10.1542/peds.2013-1985.3664
［43］CLARK S L，PORTER T F，WEST F G.Coumarin derivatives and breast-feeding［J］．Obstet Gynecol，2000，95（6 Pt 1）：938-940.3664
［44］RICHTER C，SITZMANN J，LANG P，et al．Excretion of low molecular weight heparin in human milk［J］．Br J Clin Pharmacol，2001，52（6）：708-710.3664

[1]	CHEN Junyu, HAN Guangli, LI Chunhong, CHEN Yidi, YANG Nana, LUO Xiaoxi. Classification Study of Self-management Types among Pregnant Women in Rural Areas Based on Cluster Analysis [J]. Chinese General Practice, 2025, 28(26): 3289-3293.
[2]	GU Xiaolin, CHEN Junyu, CHEN Dan, HAN Guangli, CHEN Yidi, LI Chunhong, LUO Xiaoxi. Emotional Experience of Pregnant Women in Rural China: a Qualitative Study [J]. Chinese General Practice, 2025, 28(26): 3283-3288.
[3]	XIAO Yao, WAN Jun. Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants [J]. Chinese General Practice, 2025, 28(24): 3066-3071.
[4]	CHEN Dian, LONG Huanyu, ZHANG Congxi, CHU Lanhe, LI Shurun, CHEN Yahong. Interpretation of Global Strategy for the Diagnosis, Treatment, Management and Prevention of Chronic Obstructive Pulmonary Disease 2025 Report [J]. Chinese General Practice, 2025, 28(16): 1937-1949.
[5]	YANG Jianuo, WANG Guanli, YANG Jiafu, HE Jiahao, CHEN Shumin, SHEN Yi, LI Juan, REN Ni, LIU Chunli, DENG Fangge. New Progress in the Application of Infrared Thermal Imaging in Pulmonary Diseases [J]. Chinese General Practice, 2025, 28(08): 1012-1016.
[6]	LYU Guangyu, SUN Wanjun, ZHOU Qianqian, CHEN Xianmeng, LIU Xuehan, HU Xiaowen. Clinical Characteristics and Risk Factors of Patients with Pulmonary Infarction Secondary to Intermediate and High-risk Pulmonary Embolism Misdiagnosed as Pneumonia [J]. Chinese General Practice, 2024, 27(32): 3987-3992.
[7]	Chinese Association of Geriatric Sleep Medicine, Chinese Geriatrics Society. Chinese Consensus on Application Speifications for Noninvasive Positive Pressure Ventilation of Elderly Patients with Obstructive Sleep Apnea [J]. Chinese General Practice, 2024, 27(31): 3841-3849.
[8]	WANG Wuchao, LIU Siqi, LIU Qianqian, ZHU Jihong. Clinical Characteristics of Acute Pulmonary Embolism Complicated with Thrombocytopenia: a Retrospective Study [J]. Chinese General Practice, 2024, 27(27): 3372-3377.
[9]	HONG Ling, LU Liping, CHENG Ning, SUN Qin, JIANG Jianhong, ZHU Liangfeng. Prevalence and Epidemiological Characteristics of Venous Thromboembolism in Jiaxing City [J]. Chinese General Practice, 2024, 27(15): 1837-1842.
[10]	CHEN Dian, LONG Huanyu, LI Shurun, CHEN Yahong. Interpretation of Global Strategy for the Diagnosis, Treatment, Management and Prevention of Chronic Obstructive Pulmonary Disease 2024 Report [J]. Chinese General Practice, 2024, 27(13): 1533-1543.
[11]	ZHAO Ru, HAN Chen, HUANG Zeyu, WANG Qian, HU Jun, GE Zhijuan, BI Yan, SHEN Shanmei. Correlation of Serum Uric Acid and Serum Uric Acid/Creatinine Ratio Levels with Adverse Pregnancy Outcomes in Late Pregnancy [J]. Chinese General Practice, 2024, 27(09): 1074-1081.
[12]	ZENG Lingcong, ZHANG Longju, ZHOU Ling, ZHANG Wei, DAI Meng, HUANG Yin, HUANG Yi. Analysis of the Predictive Value of 4-level Clinical Pretest Probability Score in Elderly Patients with Acute Pulmonary Embolism [J]. Chinese General Practice, 2024, 27(09): 1062-1067.
[13]	Quality Assessment Group for Quantitative Research, Systematic Review and Guidelines/Consensus of Chinese General Practice. Report on Methodological Quality Assessment of Primary Care and General Practice Research in China in 2021: Quantitative Research, Systematic Review and Guidelines/Consensus Section [J]. Chinese General Practice, 2024, 27(07): 773-783.
[14]	YUAN Xianxian, LI Jing, WANG Jia, ZHANG Kexin, YANG Ruihua, ZHENG Wei, LI Guanghui. Prevalence of Dyslipidemia in Pregnancy and Early Predictive Value of Blood Lipid Levels [J]. Chinese General Practice, 2024, 27(06): 670-678.
[15]	SUN Yuxin, ZHAN Haoran, AYIXIAMU· Keyimu, XU Tingting. Maternal Quality of Life and Influencing Factors in Rural China [J]. Chinese General Practice, 2024, 27(06): 656-662.